Emmaus Life Sciences (EMMA) Research & Development (2010 - 2026)
Emmaus Life Sciences (EMMA) posted Research & Development of $116,000 for Q2 2026, up 107.1% from $56,000 a year earlier and up 190.0% from the prior quarter.
Powered by 
Analysis
Emmaus Life Sciences (EMMA) Research & Development (2010 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Research & Development at Emmaus Life Sciences was $237,000, down 54.0% year-over-year; for FY2025, it was $313,000, down 52.4% from FY2024.
- Annual Research & Development has declined for four consecutive years, with a five-year compound annual growth rate of -33.5% (FY2020 to FY2025).
- In prior years, Emmaus Life Sciences' Research & Development was $657,000 in FY2024 (-44.7%), $1.19 million in FY2023 (-31.1%), $1.73 million in FY2022 (-58.0%) and $4.11 million in FY2021 (+70.7%).
- The Q2 2026 figure stands as the highest quarterly Research & Development since Q1 2025.
- On a year-over-year basis, Research & Development increased in 1 of the last eight quarters, with an average decline of 33.7%.
- The strongest year-over-year quarter for Research & Development in the past five years was Q2 2026, with growth of 107.1%; the weakest was Q4 2025, with a decline of 77.4%.
- According to Business Quant data, Research & Development for the three prior quarters was $40,000 (Q1 2026), $31,000 (Q4 2025) and $50,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,163.48 Bn | 1,132.06 Bn | 19.71 Bn | 3.82 Bn |
| 2 | Johnson & Johnson | 631.16 Bn | 549.69 Bn | 17.26 Bn | 3.65 Bn |
| 3 | AbbVie | 502.63 Bn | 475.74 Bn | 12.70 Bn | 2.34 Bn |
| 4 | Merck | 378.53 Bn | 332.91 Bn | 12.21 Bn | 9.74 Bn |
| 5 | Novartis Ag | 302.83 Bn | 266.82 Bn | 11.24 Bn | 2.85 Bn |
| 6 | Astrazeneca | 265.92 Bn | 239.60 Bn | 12.86 Bn | 4.05 Bn |
| 7 | Amgen | 240.87 Bn | 196.27 Bn | 7.24 Bn | 1.87 Bn |
| 8 | Gilead Sciences | 194.04 Bn | 168.24 Bn | 6.22 Bn | 1.76 Bn |
| 9 | Pfizer | 172.14 Bn | 118.78 Bn | 10.94 Bn | 2.81 Bn |
| 10 | Emmaus Life Sciences | 3.51 Mn | -2.79 Mn | 5.97 Mn | 116,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 116,000.00 |
| Mar 31, 2026 | 40,000.00 |
| Dec 31, 2025 | 31,000.00 |
| Sep 30, 2025 | 50,000.00 |
| Jun 30, 2025 | 56,000.00 |
| Mar 31, 2025 | 176,000.00 |
| Dec 31, 2024 | 137,000.00 |
| Sep 30, 2024 | 146,000.00 |
| Jun 30, 2024 | 191,000.00 |
| Mar 31, 2024 | 183,000.00 |
| Dec 31, 2023 | 166,000.00 |
| Sep 30, 2023 | 414,000.00 |
| Jun 30, 2023 | 320,000.00 |
| Mar 31, 2023 | 289,000.00 |
| Dec 31, 2022 | 529,000.00 |
| Sep 30, 2022 | 432,000.00 |
| Jun 30, 2022 | 298,000.00 |
| Mar 31, 2022 | 466,000.00 |
| Dec 31, 2021 | 1.08 Mn |
| Sep 30, 2021 | 470,000.00 |
API Access
Emmaus Life Sciences Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=EMMA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "EMMA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=EMMA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();